Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Genetic risk factors for Clostridium difficile infection in ulcerative colitis

This month's issue of the Alimentary Pharmacology & Therapeutics evaluates genetic risk factors for Clostridium difficile infection in ulcerative colitis.

News image

Patients with inflammatory bowel disease are at higher risk for Clostridium difficile infection.

Disruption of gut microbiome and interaction with the intestinal immune system are essential mechanisms for pathogenesis of both Clostridium difficile infection and inflammatory bowel disease.

Dr Ananthakrishnan from Massachusetts, USA and fellow researchers conducted whether genetic polymorphisms associated with susceptibility to inflammatory bowel disease are also associated with risk of Clostridium difficile infection is unknown.

The team evaluated a well-characterized and genotyped cohort of patients with ulcerative colitis to identify clinical risk factors for Clostridium difficile.

The researchers examined if any of the inflammatory bowel disease genetic risk loci were associated withClostridium difficile infection, and compared the performance of predictive models using clinical and genetic risk factors in determining risk of Clostridium difficile infection.

The doctors used a prospective registry of patients from a tertiary referral hospital.

Medical record review was performed to identify all ulcerative colitis patients within the registry with a history of Clostridium difficile infection.

The genetic loci explained 28% of the variance in C difficile risk
Alimentary Pharmacology & Therapeutics

All patients were genotyped on the Immunochip.

The doctors examined the association between the 163 risk loci for inflammatory bowel disease, and risk of Clostridium difficile using a dominant genetic model.

Model performance was examined using receiver operating characteristics curves.

The study included 319 patients of whom 29 developed Clostridium difficile infection.

Female gender and pancolitis were associated with increased risk, while use of anti-TNF was protective against Clostridium difficile infection.

The researchers identified 6 genetic polymorphisms including those at TNFRSF14 that were associated with increased risk while 2 loci were inversely associated.

The research team found that none of the clinical parameters retained significance after adjusting for genetics.

Presence of at least 1 high-risk locus was associated with an increase in risk for Clostridium difficile infection.

Compared to 11% for a clinical model, the genetic loci explained 28% of the variance in Clostridium difficile risk.

Dr Ananthakrishnan's team concludes, "Host genetics may influence susceptibility to Clostridium difficile infection in patients with ulcerative colitis."

Aliment Pharmacol & Ther 2013: 38(5) 522530
06 September 2013

Go to top of page Email this page Email this page to a colleague

 28 April 2015

Advanced search
 28 April 2015 
Alcohol drinking and risk of liver cirrhosis
 28 April 2015 
Clinical outcomes after esophagectomy
 28 April 2015 
Risk factors of hepatocellular carcinoma
 24 April 2015 
GastroHep.com Easter break
 23 April 2015 
Gut microbiota modulation for alcoholic liver disease
 23 April 2015 
Moderate sodium restriction diet in cirrhosis
 23 April 2015 
Gastroesophageal junction disruption and obesity
 22 April 2015 
Hepatitis and mortality in hospitalized patients
 22 April 2015 
Magnetic sphincter augmentation for GERD
 22 April 2015 
Drug, herbal and dietary supplement hepatotoxicity
 21 April 2015 
Risk factors of postpartum bowel changes
 21 April 2015 
Tracking colonoscopy surveillance intervals
 21 April 2015 
PPI increases risk of cryptogenic liver abscess
 20 April 2015 
IBS after traveller's diarhea
 20 April 2015 
Economic impact of C. diff infection
 20 April 2015 
Adherence to Hep C treatments
 17 April 2015 
Synchronous colorectal advanced neoplasia
 17 April 2015 
PNPLA3 polymorphisms and NAFLD risk
 17 April 2015 
MELD score and colorectal resection
 16 April 2015 
Bleeding risk in colonic diverticulosis
 16 April 2015 
Minority use of high-volume hospitals for colorectal cancer
 16 April 2015 
Sleep and IBD
 15 April 2015 
Treatment of hepatocellular carcinoma
 15 April 2015 
Score predicts malignant bile duct obstruction
 15 April 2015 
Increased risk of Barrett esophagus
 14 April 2015 
Improving colorectal cancer screening uptake
 14 April 2015 
Colorectal cancer presenting under the age of 50
 14 April 2015 
Functional constipation vs constipation predominant IBS
 13 April 2015 
Fecal transplant for C. difficile
 13 April 2015 
Immune based treatments for HCC
 13 April 2015 
CRP and acute diverticulitis
 10 April 2015 
Hypnotherapy for IBS
 10 April 2015 
Adjuvant therapy after rectal cancer
 10 April 2015 
Viral outcomes in HCV infection
 09 April 2015 
Male IBD patients wishing to conceive
 09 April 2015 
Screening programs based on the fecal immunochemical test
 09 April 2015 
Management of esophageal food impaction
 08 April 2015 
Nonceliac gluten sensitivity
 08 April 2015 
Ambulatory hemorrhoidal surgery
 08 April 2015 
Iron fortification and gut inflammation
 07 April 2015 
Endoscopic managements of GI bleeds
 07 April 2015 
Interventions for eosinophilic esophagitis
 07 April 2015 
Treatment of Hep C virus
 06 April 2015 
Treatment for rectal cancer
 06 April 2015 
Risk stratifying Barrett's esophagus
 06 April 2015 
Cost-effectiveness of HCV
 03 April 2015 
Predicting advanced cancer in Barrett's
 03 April 2015 
Vitamin D deficiency and Hep B outcomes
 03 April 2015 
Hepatocellular carcinoma surveillance in cirrhosis
 02 April 2015 
Physical activity and NAFLD
 02 April 2015 
Genetic risk for Crohn's disease
 02 April 2015 
EUS for detection of pancreatic neuroendocrine tumors
 01 April 2015 
Analysis of liver fibrosis
 01 April 2015 
Obeticholic acid in primary biliary cirrhosis
 01 April 2015 
Mortality rates for upper GI bleeds
 31 March 2015 
HCV-HIV co-infection combination therapy
 31 March 2015 
Placement of nasoenteral feeding tubes
 31 March 2015 
Hepatic fat and gallbladder polyps
 30 March 2015 
Minimally invasive approach in colorectal procedures
 30 March 2015 
Prevalence of IBD in USA residents of Indian ancestry

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us